生物制药公司PolyPid因未满足股东股权要求而得到Nasdaq的警告。 Biopharmaceutical firm PolyPid gets Nasdaq warning for not meeting stockholders' equity requirement.

生物制药公司PollyPid已经收到Nasdaq的通知,称其不符合最低股东股本要求。 Biopharmaceutical company PolyPid has received a notification from Nasdaq for not meeting the minimum stockholders' equity requirement. 截至9月30日,PolyPid股东的股权约为216万美元,未能达到Nasdaq上市规则所要求的250万美元的门槛值。 As of September 30, PolyPid's stockholders' equity was about $2.16 million, failing to meet the $2.5 million threshold required by Nasdaq's listing rules.